Skip to Content
Merck
CN

HPLC Analysis of Benzodiazepines on Ascentis® Express Phenyl-Hexyl, Methanol Mobile Phase

HPLC Analysis of Benzodiazepines on Ascentis® Express Phenyl-Hexyl, Methanol Mobile Phase application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express Phenyl-Hexyl, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 5 cm × 4.6 mm

standard

Product No.
Description
Pricing

Desmethyldiazepam

analytical standard

Oxazepam solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Alprazolam solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Clonazepam solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Diazepam solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express Phenyl-Hexyl, 5 cm x 4.6 mm I.D., 2.7 μm particles (53348-U)

mobile phase

[A] water; [B] methanol; (35:65, A:B)

flow rate

1.4 mL/min

pressure

3600 psi (248 bar)

column temp.

35 °C

detector

UV, 250 nm

injection

2 μL

sample

0.1 g/L in 20% methanol

Description

Analysis Note

The Phenyl-Hexyl phase of the Ascentis Express product line displays the best selectivity of this sample; selectivity is markedly affected by choice of organic modifier. The application also demonstrates feasibility of fast LC with Ascentis Express by virtue of low backpressure and high efficiency.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany